Showing 2 of 22 recruiting trials for “high-grade-neuroendocrine-carcinoma-of-the-corpus-uteri”
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →